1-160135928-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 3P and 6B. PM1PP2BP4_ModerateBS2
The ENST00000361216.8(ATP1A2):āc.2374A>Gā(p.Ile792Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000361216.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1A2 | NM_000702.4 | c.2374A>G | p.Ile792Val | missense_variant | 17/23 | ENST00000361216.8 | NP_000693.1 | |
ATP1A2 | XM_047421286.1 | c.1483A>G | p.Ile495Val | missense_variant | 10/16 | XP_047277242.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1A2 | ENST00000361216.8 | c.2374A>G | p.Ile792Val | missense_variant | 17/23 | 1 | NM_000702.4 | ENSP00000354490 | P1 | |
ATP1A2 | ENST00000392233.7 | c.2374A>G | p.Ile792Val | missense_variant | 17/23 | 5 | ENSP00000376066 | |||
ATP1A2 | ENST00000447527.1 | c.1507A>G | p.Ile503Val | missense_variant | 10/16 | 2 | ENSP00000411705 | |||
ATP1A2 | ENST00000472488.5 | n.2477A>G | non_coding_transcript_exon_variant | 17/20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151738Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251468Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135906
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.0000303 AC XY: 22AN XY: 727248
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151738Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74076
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2018 | p.Ile792Val (ATT>GTT): c.2374 A>G in exon 17 of the ATP1A2 gene (NM_000702.3). The I792V missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The I792V variant alters a conserved position in the ATP1A2 protein. However, the amino acid substitution is conservative, which is not likely to impact secondary protein structure as these residues share similar properties. In silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether I792V is a disease-causing mutation or a rare benign variant. The variant is found in ADULT-EPI,EPILEPSY panel(s). - |
Familial hemiplegic migraine Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 792 of the ATP1A2 protein (p.Ile792Val). This variant is present in population databases (rs758749177, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 204897). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATP1A2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at